EGFR and cancer: Activation of receptor tyrosine kinases, such as the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), leads to increased mTOR activity and increased HIF-1α mRNA translation into protein in prostate (30) and breast (32) cancer, respectively.